Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


30.07.2018

2 Acta Neurol Scand
1 Clin Exp Immunol
1 J Neurol Sci
1 J Neurosci Res
1 Lancet Neurol
7 Mult Scler
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. MURLEY C, Yang F, Gyllensten H, Alexanderson K, et al
    Disposable income trajectories of working-aged individuals with diagnosed multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 24. doi: 10.1111/ane.13001.
    PubMed     Text format     Abstract available

  2. ROMEO MAL, Martinelli V, Dalla Costa G, Colombo B, et al
    Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.
    Acta Neurol Scand. 2018 Jul 22. doi: 10.1111/ane.12999.
    PubMed     Text format     Abstract available


    Clin Exp Immunol

  3. FUJIWARA M, Anstadt EJ, Flynn B, Morse K, et al
    Enhanced TLR2 responses in multiple sclerosis.
    Clin Exp Immunol. 2018 Jul 24. doi: 10.1111/cei.13150.
    PubMed     Text format     Abstract available


    J Neurol Sci

  4. KHALID F, Healy BC, Dupuy SL, Chu R, et al
    Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
    J Neurol Sci. 2018;392:94-99.
    PubMed     Text format     Abstract available


    J Neurosci Res

  5. SCAZZONE C, Agnello L, Ragonese P, Lo Sasso B, et al
    Association of CYP2R1 rs10766197 with MS risk and disease progression.
    J Neurosci Res. 2018;96:297-304.
    PubMed     Text format     Abstract available


    Lancet Neurol

  6. MACARON G, Cohen JA
    Integrating multiple sclerosis guidelines into practice.
    Lancet Neurol. 2018;17:658-660.
    PubMed     Text format    


    Mult Scler

  7. CORTESE R, Ciccarelli O
    Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Yes.
    Mult Scler. 2018 Jul 1:1352458518778010. doi: 10.1177/1352458518778010.
    PubMed     Text format    

  8. SASTRE-GARRIGA J
    Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Commentary.
    Mult Scler. 2018 Jul 1:1352458518783362. doi: 10.1177/1352458518783362.
    PubMed     Text format    

  9. KEARNEY H
    Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - No.
    Mult Scler. 2018 Jul 1:1352458518770279. doi: 10.1177/1352458518770279.
    PubMed     Text format    

  10. COHEN JA, Comi G, Arnold DL, Bar-Or A, et al
    Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.
    Mult Scler. 2018 Jul 25:1352458518789884. doi: 10.1177/1352458518789884.
    PubMed     Text format     Abstract available

  11. HOLM HANSEN R, Hojsgaard Chow H, Sellebjerg F, Rode von Essen M, et al
    Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis.
    Mult Scler. 2018 Jul 25:1352458518790417. doi: 10.1177/1352458518790417.
    PubMed     Text format     Abstract available

  12. HYUN JW, Kim W, Huh SY, Park MS, et al
    Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome.
    Mult Scler. 2018 Jul 25:1352458518790702. doi: 10.1177/1352458518790702.
    PubMed     Text format     Abstract available

  13. SACCA F, Lanzillo R, Signori A, Maniscalco GT, et al
    Determinants of therapy switch in multiple sclerosis treatment-naive patients: A real-life study.
    Mult Scler. 2018 Jul 25:1352458518790390. doi: 10.1177/1352458518790390.
    PubMed     Text format     Abstract available


    Rev Neurol

  14. MALLADA-FRECHIN J, Meca-Lallana V, Barrero F, Martinez-Gines ML, et al
    [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
    Rev Neurol. 2018;67:157-167.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: